CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,184,000 | +46.2% | 168,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $810,000 | -26.0% | 168,700 | -10.1% | 0.00% | 0.0% |
| Q3 2020 | $1,094,000 | +10.7% | 187,683 | +28.3% | 0.00% | 0.0% |
| Q2 2020 | $988,000 | +51.3% | 146,300 | +42.6% | 0.00% | 0.0% |
| Q1 2020 | $653,000 | -73.8% | 102,600 | -57.1% | 0.00% | -50.0% |
| Q4 2019 | $2,493,000 | +855.2% | 239,116 | +260.7% | 0.00% | – |
| Q3 2019 | $261,000 | -69.2% | 66,300 | +16.3% | 0.00% | -100.0% |
| Q2 2019 | $848,000 | -41.0% | 57,000 | -1.6% | 0.00% | -50.0% |
| Q1 2019 | $1,437,000 | +34.4% | 57,900 | -2.7% | 0.00% | +100.0% |
| Q4 2018 | $1,069,000 | -44.4% | 59,500 | -9.0% | 0.00% | -50.0% |
| Q3 2018 | $1,921,000 | -40.3% | 65,400 | -7.6% | 0.00% | -50.0% |
| Q2 2018 | $3,219,000 | -28.2% | 70,800 | -16.6% | 0.00% | -33.3% |
| Q1 2018 | $4,483,000 | -32.2% | 84,900 | -12.6% | 0.01% | -33.3% |
| Q4 2017 | $6,609,000 | +140.2% | 97,184 | +191.1% | 0.01% | +125.0% |
| Q3 2017 | $2,751,000 | -1.8% | 33,384 | +11.7% | 0.00% | 0.0% |
| Q2 2017 | $2,800,000 | +59.4% | 29,900 | +8.3% | 0.00% | +33.3% |
| Q1 2017 | $1,757,000 | +58.9% | 27,600 | +10.8% | 0.00% | +50.0% |
| Q4 2016 | $1,106,000 | +23.2% | 24,900 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $898,000 | +145.4% | 24,900 | -6.7% | 0.00% | 0.0% |
| Q2 2016 | $366,000 | -30.9% | 26,700 | -3.3% | 0.00% | 0.0% |
| Q1 2016 | $530,000 | -48.5% | 27,600 | -6.1% | 0.00% | -50.0% |
| Q4 2015 | $1,029,000 | -68.8% | 29,400 | -18.1% | 0.00% | -66.7% |
| Q3 2015 | $3,301,000 | +11.1% | 35,900 | +6.2% | 0.01% | +50.0% |
| Q2 2015 | $2,970,000 | +14.2% | 33,800 | -11.1% | 0.00% | 0.0% |
| Q1 2015 | $2,601,000 | 0.0% | 38,002 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,601,000 | +411.0% | 38,002 | +238.8% | 0.00% | +300.0% |
| Q3 2014 | $509,000 | +45.8% | 11,216 | +33.1% | 0.00% | – |
| Q2 2014 | $349,000 | -33.9% | 8,427 | +4.4% | 0.00% | -100.0% |
| Q1 2014 | $528,000 | +1127.9% | 8,071 | +1053.0% | 0.00% | – |
| Q3 2013 | $43,000 | -99.7% | 700 | -99.7% | 0.00% | -100.0% |
| Q2 2013 | $15,670,000 | – | 233,943 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |